Salt Lake City, UT – February 20, 2007 - BioMicro® Systems announces the appointment of Rob Parry as Vice President of Manufacturing, responsible for expanding the company's manufacturing operations to meet the high demand for the MAUI® Hybridization System product line.

BioMicro Systems is a private company that serves the life sciences community by developing and marketing biological research products based on its proprietary microfluidic and microarray technologies.

Mr. Parry has held top level manufacturing positions in several instrument and consumable businesses. Most recently, he established and expanded the manufacturing operations for Nanosys, Inc., a leading nanotechnology company. As Vice President of Manufacturing at Fluidigm, a microfluidics start-up, and prior to that at Agilent Technologies in the DNA microarray business, Mr. Parry successfully developed and scaled-up commercial production for two completely novel technologies. His innovative and effective leadership delivered cost effective processes with consistent high quality and availability of products.

“I am excited to have Rob Parry in a pivotal role at BioMicro Systems as we implement an aggressive growth strategy targeting a broader customer base,” stated Michael Feldman, Ph.D., Chief Executive Officer of BioMicro Systems. “He brings extensive experience in both DNA microarrays and microfluidics forming an excellent fit with the BioMicro Systems growing product line.”

Mr. Parry added, “I look forward to joining a growing company with a technology and product line that has already been validated by successful sales. I am anxious to contribute my breadth of knowledge and experience in further building the company's manufacturing and quality systems.” Mr. Parry received a B.S.M.E. from Cal Poly, San Luis Obispo, and an M.S. from MIT in Operations Management and Technology Innovation.

About BioMicro Systems, Inc.:
BioMicro Systems, Inc., founded in 2000 and based in Salt Lake City, Utah, is a private company focused on the development and commercialization of biological research products based on its proprietary microfluid and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. To date, over 300 MAUI Systems have been sold worldwide. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results.
More company information can be found at: www.biomicro.com

Media contact:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax:     +49 (0)69-21 93 96 122
e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it